News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Pennington James
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/03/2022 |
4
| Pennington James (CHIEF MEDICAL OFFICER) has filed a Form 4 on First Wave BioPharma, Inc.|
Txns:
| Granted 7,500 options to buy
@ $1.45, valued at
$10.9k
|
|
| 07/09/2021 |
4
| Pennington James (CHIEF MEDICAL OFFICER) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.75, valued at
$75k
|
|
| 07/20/2020 |
4
| Pennington James (CHIEF MEDICAL OFFICER) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 300,000 options to buy
@ $0.85, valued at
$255k
|
|
| 07/20/2020 |
4
| Pennington James (CHIEF MEDICAL OFFICER) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 110,000 options to buy
@ $1.75, valued at
$192.5k
|
|
| 07/19/2018 |
4
| Pennington James (CHIEF MEDICAL OFFICER) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 75,000 options
@ $3.04, valued at
$228k
|
|
| 06/04/2018 |
3
| Pennington James (Chief Medical Officer) has filed a Form 3 on AzurRx BioPharma, Inc. |
| 04/05/2016 |
3
| Pennington James (Interim Chief Medical Officer) has filed a Form 3 on Anthera Pharmaceuticals Inc |
|
|